Funding to advance EXPD-101, a Phase 2–ready, once-daily, oral DPP1 inhibitor with first-in-class potential into a global development program in COPD, and a broad spectrum of other neutrophil-driven ...

Home-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but access is still a challenge. "The science shows that there is greater benefit ...

Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according to a gold-standard randomzed-controlled trial presented at the European Respiratory ...

While treatment with benralizumab showed numerical improvement over placebo for the primary endpoint, the result was not statistically significant. A phase 3 trial evaluating benralizumab for the ...

Please provide your email address to receive an email when new articles are posted on . Length of stay was 1 day longer for those with asthma-COPD overlap vs. COPD or asthma alone and the cost was ...

‘It’s Going to Be Nasty’: Trump Issues Warning to Hamas U.S. Navy raids tuna boat in Caribbean, Venezuela says, as tensions escalate Charlie Sheen can never unsee a water buffalo getting its head ...

Regeneron Pharmaceuticals ((REGN)), Sanofi SA ((SNY)), Sanofi ((SNYNF)), Sanofi ((DE:SNW)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock ...

Nuuk, Sermersooq , June 10, 2025 (GLOBE NEWSWIRE) -- Sammivik Media Group, a creative health communication agency based in Nuuk, Greenland, is launching a new animated video series focused on chronic ...

The MarketWatch News Department was not involved in the creation of this content. Nuuk, Sermersooq , June 10, 2025 (GLOBE NEWSWIRE) -- Sammivik Media Group, a creative health communication agency ...